Miron, B., Hoffman-Censits, J. H., Anari, F., O’Neill, J., Geynisman, D. M., Zibelman, M. R., . . . Plimack, E. R. (2020). Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer. Eur Urol Oncol.
シカゴスタイル引用形Miron, Benjamin, et al. "Defects in DNA Repair Genes Confer Improved Long-term Survival After Cisplatin-based Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer." Eur Urol Oncol 2020.
MLA引用形式Miron, Benjamin, et al. "Defects in DNA Repair Genes Confer Improved Long-term Survival After Cisplatin-based Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer." Eur Urol Oncol 2020.
警告: この引用は必ずしも正確ではありません.